SCHEMBL6557151

SCHEMBL6557151

CCOc1cc(Cc2cnc(N)nc2N)cc(OCC(C)C)c1-c1ccc(OCOC)cc1

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.58
DHFR P00374 4/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6557341 0.93 DHFR (0.60) DHFR
SCHEMBL6555451 0.92 LMNA (0.58) LMNADHFR
SCHEMBL6556772 0.91 DHFR (0.53) LMNADHFR
SCHEMBL6555245 0.87 DHFR (0.55) DHFR
SCHEMBL6555471 0.87 LMNA (0.54) LMNADHFR
SCHEMBL6555466 0.86 NTRK1 (0.53) DHFR
SCHEMBL6555338 0.85 DHFR (0.51) DHFR
SCHEMBL6555422 0.85 DHFR (0.50) DHFR
SCHEMBL6555229 0.85 DHFR (0.50) DHFR
SCHEMBL6875102 0.85 DHFR (0.46) DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1230224-B1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2004-12-29 EP disclosed
US-6821980-B1 Substituted 5-benzyl-2,4-diaminopyrimidines BASILEA PHARMACEUTICA AG (CH) 2004-11-23 US disclosed
EP-1230224-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES F. HOFFMANN-LA ROCHE AG (CH) 2002-08-14 EP disclosed
WO-2001032633-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2001-05-10 WO disclosed